Felix Baker's Net Worth
Felix Baker's net worth is estimated to be at least $933,033,708.08 as of 11/22/2024. CoreStreet's estimation of Felix Baker's net worth is based on their sale of stock and current holding of stock.
Felix Baker is Director at Seagen Inc. They have executed at least 40 trades of stock as per SEC Form 4 filings. Their most recent trade was for 382,500 units of SGEN stock on 11/08/2016. Their biggest sale was on when they sold units of stock for $. They typically trade 10 times per year.
Total value of insider buys:
- $933,033,708.08
Total value of insider sells:
- $0.00
Most recent insider trade:
- Nov. 8, 2016
Felix Baker's Insider Trading History
| Seagen Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 8, 2016 | Director | 382,500 | $59.36 | Buy | $22,705,200.00 |
Nov. 3, 2016 | Director | 1,030,629 | $56.13 | Buy | $57,849,205.77 |
Sept. 13, 2016 | Director | 447,311 | $50.71 | Buy | $22,683,140.81 |
Sept. 8, 2016 | Director | 414,016 | $48.43 | Buy | $20,050,794.88 |
March 17, 2016 | Director | 124,065 | $31.85 | Buy | $3,951,470.25 |
March 16, 2016 | Director | 1,349,237 | $32.10 | Buy | $43,310,507.70 |
March 15, 2016 | Director | 661,093 | $32.08 | Buy | $21,207,863.44 |
March 14, 2016 | Director | 118,941 | $33.77 | Buy | $4,016,637.57 |
March 11, 2016 | Director | 694,666 | $32.46 | Buy | $22,548,858.36 |
March 8, 2016 | Director | 502,523 | $22.66 | Buy | $11,387,171.18 |
March 2, 2016 | Director | 675,922 | $31.77 | Buy | $21,474,041.94 |
March 1, 2016 | Director | 24,200 | $31.24 | Buy | $756,008.00 |
Feb. 29, 2016 | Director | 251,722 | $30.39 | Buy | $7,649,831.58 |
Feb. 26, 2016 | Director | 314,508 | $29.55 | Buy | $9,293,711.40 |
Feb. 22, 2016 | Director | 1,001,471 | $29.63 | Buy | $29,673,585.73 |
Feb. 17, 2016 | Director | 1,269,147 | $30.43 | Buy | $38,620,143.21 |
Nov. 20, 2015 | Director | 329,358 | $43.94 | Buy | $14,471,990.52 |
Nov. 10, 2015 | Director | 934,624 | $42.95 | Buy | $40,142,100.80 |
Nov. 9, 2015 | Director | 507,300 | $43.76 | Buy | $22,199,448.00 |
Nov. 6, 2015 | Director | 417,924 | $41.94 | Buy | $17,527,732.56 |
May 21, 2015 | Director | 950,886 | $42.49 | Buy | $40,403,146.14 |
May 7, 2015 | Director | 1,032,664 | $35.56 | Buy | $36,721,531.84 |
March 10, 2015 | Director | 285,036 | $34.66 | Buy | $9,879,347.76 |
March 9, 2015 | Director | 275,717 | $34.66 | Buy | $9,556,351.22 |
March 4, 2015 | Director | 448,841 | $34.84 | Buy | $15,637,620.44 |
Feb. 25, 2015 | Director | 281,115 | $33.92 | Buy | $9,535,420.80 |
Dec. 16, 2014 | Director | 2,883,378 | $31.86 | Buy | $91,864,423.08 |
Dec. 10, 2014 | Director | 1,247,896 | $33.82 | Buy | $42,203,842.72 |
Dec. 9, 2014 | Director | 128,430 | $34.16 | Buy | $4,387,168.80 |
Dec. 8, 2014 | Director | 465,316 | $32.93 | Buy | $15,322,855.88 |
Nov. 10, 2014 | Director | 1,653,925 | $34.56 | Buy | $57,159,648.00 |
June 13, 2014 | Director | 216,595 | $39.92 | Buy | $8,646,472.40 |
June 9, 2014 | Director | 546,252 | $38.16 | Buy | $20,844,976.32 |
June 4, 2014 | Director | 281,963 | $34.86 | Buy | $9,829,230.18 |
May 16, 2014 | Director | 189,611 | $34.07 | Buy | $6,460,046.77 |
Dec. 16, 2013 | Director | 407,078 | $39.66 | Buy | $16,144,713.48 |
Dec. 5, 2013 | Director | 1,005,901 | $43.19 | Buy | $43,444,864.19 |
| BioCryst Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 1, 2013 | Major Shareholder | 1,136,364 | $4.40 | Buy | $5,000,001.60 |
| ACADIA Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 5, 2013 | Director | 2,340,314 | $14.34 | Buy | $33,560,102.76 |
May 15, 2013 | Director | 1,993,000 | $12.50 | Buy | $24,912,500.00 |